ISIN | LU0996778642 |
---|---|
Valor Number | 58920661 |
Bloomberg Global ID | |
Fund Name | Kieger Sustainable Healthcare Fund Class A USD Accumulating |
Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fund Provider | Kieger AG |
Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). No guarantee can be given that the investment objective will be achieved. |
Peculiarities |
Current Price * | 209.20 USD | 07.05.2025 |
---|---|---|
Previous Price * | 209.41 USD | 06.05.2025 |
52 Week High * | 239.55 USD | 30.08.2024 |
52 Week Low * | 198.67 USD | 07.04.2025 |
NAV * | 209.20 USD | 07.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 297,382,533 | |
Unit/Share Assets *** | 24,504,788 | |
Trading Information SIX |
YTD Performance | +0.82% |
31.12.2024 - 07.05.2025
31.12.2024 07.05.2025 |
---|---|---|
YTD Performance (in CHF) | -8.56% |
31.12.2024 - 07.05.2025
31.12.2024 07.05.2025 |
1 month | +5.30% |
07.04.2025 - 07.05.2025
07.04.2025 07.05.2025 |
3 months | -5.85% |
07.02.2025 - 07.05.2025
07.02.2025 07.05.2025 |
6 months | -5.46% |
07.11.2024 - 07.05.2025
07.11.2024 07.05.2025 |
1 year | -3.77% |
07.05.2024 - 07.05.2025
07.05.2024 07.05.2025 |
2 years | +3.47% |
08.05.2023 - 07.05.2025
08.05.2023 07.05.2025 |
3 years | +15.43% |
10.05.2022 - 07.05.2025
10.05.2022 07.05.2025 |
5 years | +38.63% |
12.05.2020 - 07.05.2025
12.05.2020 07.05.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 6.56% | |
---|---|---|
Abbott Laboratories | 5.73% | |
AstraZeneca PLC | 4.97% | |
Novartis AG Registered Shares | 4.87% | |
UnitedHealth Group Inc | 4.71% | |
Roche Holding AG | 4.69% | |
Novo Nordisk AS Class B | 4.44% | |
Thermo Fisher Scientific Inc | 4.27% | |
Vertex Pharmaceuticals Inc | 3.96% | |
Boston Scientific Corp | 3.66% | |
Last data update | 28.02.2025 |
TER *** | 0.99% |
---|---|
TER date *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.85% |
Ongoing Charges *** | 0.99% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |